Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening

Journal of Clinical Oncology

Volumn 27, Issue 35, 2009, Pages 5919-5923

  Autier, Philippe ^a   Héry, Clarisse ^a   Haukka, Jari ^a   Boniol, Mathieu ^a   Byrnes, Graham ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LINEAR REGRESSION ANALYSIS; MAMMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ADULT; BREAST TUMOR; CANADA; FEMALE; INCIDENCE; LYMPH NODE METASTASIS; META ANALYSIS; METASTASIS; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; STATISTICAL MODEL; SWEDEN; UNITED KINGDOM; UNITED STATES;

ADULT; BREAST NEOPLASMS; CANADA; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LINEAR MODELS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SWEDEN; UNITED STATES;

EID: 73349123198     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.7041     Document Type: Article

References (31)

1. Vainio H, Bianchini F (eds): IARC Handbooks of Cancer Prevention. Volume 7. Breast Cancer Screening. Lyon, France, IARC Press, 2002
2. US Preventive Services Task Force. Screening for breast cancer: Recommendations and rationale. Ann Intern Med 137:344-346, 2002
3. Gøtzsche PC, Nielsen M: Screening for breast cancer with mammography. Cochrane Database Syst Rev 4:CD001877, 2006
4. Tabár L, Fagerberg CJ, Gad A, et al: Reduction in mortality from breast cancer after mass screening with mammography: Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829-832, 1985
5. Chu KC, Smart CR, Tarone RE: Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 80:1125-1132, 1988
6. Day NE, Williams DR, Khaw KT: Breast cancer screening programmes: The development of a monitoring and evaluation system. Br J Cancer 59:954-958, 1989
7. Day NE: Surrogate measures in the design of breast cancer screening trials, in Miller AB, Chamberlain J, Day NE, et al (eds): Cancer Screening. New York, NY, Cambridge University Press, 1990, pp 391-403
8. Lee SJ, Zelen M: Modelling the early detection of breast cancer. Ann Oncol 14:1199-1202, 2003
9. Duffy SW, Tabar L, Vitak B, et al: The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 39:1757-1760, 2003
10. Tabár L, Vitak B, Chen HH, et al: The Swedish Two-County Trial twenty years later: Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 38:625-651, 2000
11. Andersson I, Aspegren K, Janzon L, et al: Mammographic screening and mortality from breast cancer: The Malmö mammographic screening trial. BMJ 297:943-948, 1988
12. Andersson I, Nystrom L: Mammography screening. J Natl Cancer Inst 87:1263-1264, 1995
13. Frisell J, Lidbrink E, Hellström L, et al: Followup after 11 years: Update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 45:263-270, 1997
14. Nyström L, Andersson I, Bjurstam N, et al: Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 359:909-919, 2002
15. Bjurstam N, Björneld L, Warwick J, et al: The Gothenburg Breast Screening Trial. Cancer 97:2387-2396, 2003
16. Miller AB, To T, Baines CJ, et al: The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up - A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 137:305-312, 2002
17. Miller AB, To T, Baines CJ, et al: Canadian National Breast Screening Study-2: 13-Year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 92:1490-1499, 2000
18. Moss S, Waller M, Anderson TJ, et al: Randomised controlled trial of mammographic screening in women from age 40: Predicted mortality based on surrogate outcome measures. Br J Cancer 92:955-960, 2005
19. Moss SM, Cuckle H, Evans A, et al: Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: A randomised controlled trial. Lancet 368:2053-2060, 2006
20. Tabár L, Fagerberg G, Day NE, et al: Breast cancer treatment and natural history: New insights from results of screening. Lancet 339:412-414, 1992
21. Tabàr L, Fagerberg G, Duffy SW, et al: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:187-210, 1992
22. Shapiro S, Venet W, Strax P, et al: Selection, follow-up, and analysis in the Health Insurance Plan Study: A randomized trial with breast cancer screening. Natl Cancer Inst Monogr 67:65-74, 1985
23. Shapiro S, Venet W, Strax P, Venet L: Current results of the breast cancer screening randomized trial: The health insurance plan (HIP) of greater New York study, in Day NE, Miller AB (eds): Screening for Breast Cancer. Toronto, Ontario, Canada, Hans Huber, 1988, pp 3-15
24. Cutler SJ, Black MM, Mork T, et al: Further observations on prognostic factors in cancer of the female breast. Cancer 24:653-667, 1969
25. American Joint Committee on Cancer: AJCC Cancer Staging Manual (ed 6). New York, NY, Springer, 2002, pp 171-180
26. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours (ed 6). New York, NY, Wiley-Liss, 2002
27. Petrik DW, McCready DR, Sawka CA, et al: Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. J Surg Oncol 82:84-90, 2003
28. Schaapveld M, Otter R, de Vries EG, et al: Variability in axillary lymph node dissection for breast cancer. J Surg Oncol 87:4-12, 2004
29. Smith RA, Duffy SW, Gabe R, et al: The randomized trials of breast cancer screening: What have we learned? Radiol Clin North Am 42:793-806, 2004
30. Tabar L, Chen HH, Duffy SW, et al: Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol 29:608-616, 1999
31. Rijnsburger AJ, van Oortmarssen GJ, Boer R, et al: Mammography benefit in the Canadian National Breast Screening Study-2: A model evaluation. Int J Cancer 110:756-762, 2004